Immunophenotypically heterogeneous acute T-lymphoblastic leukemia has invariable immunogenotype: Analysis of two cases

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 1, 2006, Pages 50-52

  Meleshko, Alexander ^a   Savitski, Valery P ^a   Shman, Tatsiana V ^a   Aleinikova, Olga V ^a  

^a Belarusian Research Center for Pediatric Oncology and Hematology   (Belarus)

Author keywords

Acute lymphoblastic leukemia; Immunophenotypic heterogeneity; TCR rearrangements

Indexed keywords

CD34 ANTIGEN; CELL SURFACE MARKER; STEM CELL FACTOR RECEPTOR; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; LYMPHOCYTE ANTIGEN RECEPTOR;

ACUTE LEUKEMIA; ACUTE T LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANTIGEN EXPRESSION; ARTICLE; CD34 SELECTION; CELL CYCLE S PHASE; CELL MATURATION; CELL SELECTION; CHILD; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; GENE REARRANGEMENT; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKEMIA RELAPSE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEPARATION TECHNIQUE; T LYMPHOCYTE SUBPOPULATION; CASE REPORT; GENETICS; GENOTYPE; IMMUNOLOGY; PRESCHOOL CHILD; T CELL LEUKEMIA;

ADOLESCENT; ANTIGENS, CD34; CHILD, PRESCHOOL; GENE REARRANGEMENT, T-LYMPHOCYTE; GENOTYPE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, T-CELL, ACUTE; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA;

EID: 33644839111     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Jennings CD, Foon KA. Recent advantages in flow cytometry: application to the diagnosis of hematologic malignancy. Blood. 1997;90:2863-2892.
2. Babusikova O, Konikova E, Kusenda J, et al. Aberrant markers expression in T- and B-lymphoid and myeloid leukemia cells of different differentiation stages. Neoplasma. 1999;46:277-282.
3. Van Dongen JJM, Adriaansen HJ. Immunobiology of leukemia. In: Leukemia, 6th ed. Philadelphia: WB Saunders, 1996:83.
4. Camera A, Pezzullo L. Coexistence of two distinct cell populations (CD56+TcRγδ+ and CD56+TcRγδ-) in a case of aggressive CD56+ lymphoma/leukemia. Haematologica. 2000;85:496-501.
5. Miakova NV, Hartmann R, Rudneva AE, et al. Results of the treatment of childhood acute lymphoblastic leukemia according to the Berlin-Moscow-91 protocol in 1991-2000. Vopr Onkol. 2002;48:340-346.
6. Pongers-Willemse MJ, Seriu T, Stolz F, et al. Primers and protocols for standardized MRD detection in ALL using immunoglobulin and T cell receptor gene rearrangements and TAL1deletions as PCR targets: report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia. 1999;13:110-118.
7. Langerak AW, Wolvers-Tettero ILM, van den Beemd MWM, et al. Immunophenotypic and immunogenotypic characteristics of TCRγδ T cell acute lymphoblastic leukemia. Leukemia. 1999;13:206-214.
8. Wang YH, Zhang Z. V(D)J recombinatorial repertoire diversification during intraclonal pro-B to B-cell differentiation. Blood. 2003;101:1030-1036.
9. Shah MA, Schwartz GK. The relevance of drug sequence in combination chemotherapy. Drug Resist Update. 2000;3:335-356.